IShares Genomics Stock Options
| IDNA Etf | USD 21.71 0.47 2.12% |
IShares Genomics' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.27. The IShares Genomics option chain provides detailed quote and price information for the current iShares Genomics Immunology option contracts. It shows all of IShares Genomics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on IShares Genomics
Analyzing IShares Genomics' in-the-money options over time can help investors to take a profitable long position in IShares Genomics regardless of its overall volatility. This is especially true when IShares Genomics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money IShares Genomics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with IShares Genomics' stock while costing only a fraction of its price.
IShares Genomics' stock options are financial instruments that give investors the right to buy or sell shares of iShares Genomics Imm common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell IShares stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If IShares Genomics' stock price goes up or down, the stock options follow.
iShares Genomics Imm In The Money Call Balance
When IShares Genomics' strike price is surpassing the current stock price, the option contract against iShares Genomics Immunology stock is said to be in the money. When it comes to buying IShares Genomics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on iShares Genomics Immunology are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
IShares Current Options Market Mood
IShares Genomics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps IShares Etf's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Using current IShares Genomics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current IShares contract
Base on the Rule 16, the options market is currently suggesting that iShares Genomics Immunology will have an average daily up or down price movement of about 0.0169% per day over the life of the 2025-06-20 option contract. With IShares Genomics trading at USD 21.71, that is roughly USD 0.003664. If you think that the market is fully incorporating IShares Genomics' daily price movement you should consider buying iShares Genomics Immunology options at the current volatility level of 0.27%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
IShares |
Purchasing IShares Genomics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" IShares calls. Remember, the seller must deliver iShares Genomics Immunology stock to the call owner when a call is exercised.
IShares Genomics Option Chain
When IShares Genomics' strike price is surpassing the current stock price, the option contract against iShares Genomics Immunology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
IShares Genomics' option chain is a display of a range of information that helps investors for ways to trade options on IShares. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for IShares. It also shows strike prices and maturity days for a IShares Genomics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | IDNA250620C00029000 | 0 | 29.0 | 0.0 - 0.2 | 0.2 | |
Call | IDNA250620C00028000 | 6 | 28.0 | 0.0 - 0.2 | 0.65 | Out |
Call | IDNA250620C00027000 | 0 | 27.0 | 0.0 - 1.5 | 1.5 | |
Call | IDNA250620C00026000 | 0 | 26.0 | 0.0 - 1.55 | 1.55 | |
Call | IDNA250620C00025000 | 3 | 25.0 | 0.05 - 0.4 | 0.55 | Out |
Call | IDNA250620C00024000 | 0 | 24.0 | 0.0 - 0.9 | 0.9 | |
Call | IDNA250620C00023000 | 0 | 23.0 | 0.0 - 2.15 | 2.15 | |
Call | IDNA250620C00022000 | 0 | 22.0 | 0.0 - 2.6 | 2.6 | In |
Call | IDNA250620C00021000 | 0 | 21.0 | 0.5 - 3.3 | 0.5 | In |
Call | IDNA250620C00020000 | 0 | 20.0 | 1.2 - 3.9 | 1.2 | In |
Put | IDNA250620P00029000 | 0 | 29.0 | 5.7 - 8.4 | 5.7 | In |
Put | IDNA250620P00028000 | 0 | 28.0 | 4.7 - 7.4 | 4.7 | In |
Put | IDNA250620P00027000 | 0 | 27.0 | 3.7 - 6.4 | 2.95 | In |
Put | IDNA250620P00026000 | 0 | 26.0 | 2.7 - 5.6 | 2.7 | In |
Put | IDNA250620P00025000 | 0 | 25.0 | 1.85 - 4.6 | 1.85 | In |
Put | IDNA250620P00024000 | 0 | 24.0 | 1.05 - 3.9 | 1.05 | In |
Put | IDNA250620P00023000 | 0 | 23.0 | 0.3 - 3.2 | 0.3 | In |
Put | IDNA250620P00022000 | 0 | 22.0 | 0.0 - 2.55 | 2.55 | |
Put | IDNA250620P00021000 | 0 | 21.0 | 0.0 - 2.2 | 2.2 | |
Put | IDNA250620P00020000 | 0 | 20.0 | 0.0 - 1.9 | 1.9 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Genomics Immunology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
The market value of iShares Genomics Imm is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Genomics' value that differs from its market value or its book value, called intrinsic value, which is IShares Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Genomics' market value can be influenced by many factors that don't directly affect IShares Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.